Sensitivity of US and FNAC for staging of the axilla in patients presenting with symptomatic breast cancer

por Lister, Diane, Al-Attar, Miaad, Denton, Elizabeth, Grosvenor, Lisa, McDonald, Gayle, Purnell, Dave
Publicado 2015

Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2...

por Rakha, Emad A., Miligy, Islam M., Quinn, Cecily M., Provenzano, Elena, Shaaban, Abeer M., Marchiò, Caterina, Toss, Michael S., Gallagy, Grace, Murray, Ciara, Walshe, Janice, Katayama, Ayaka, Eldib, Karim, Badr, Nahla, Tanchel, Bruce, Millican-Slater, Rebecca, Purdie, Colin, Purnell, Dave, Pinder, Sarah E., Ellis, Ian O., Lee, Andrew H. S.
Publicado 2021

Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer

por Katayama, Ayaka, Miligy, Islam M., Shiino, Sho, Toss, Michael S., Eldib, Karim, Kurozumi, Sasagu, Quinn, Cecily M., Badr, Nahla, Murray, Ciara, Provenzano, Elena, Callagy, Grace, Martyn, Cian, Millican-Slater, Rebecca, Purdie, Colin, Purnell, Dave, Pinder, Sarah E., Oyama, Tetsunari, Shaaban, Abeer M., Ellis, Ian, Lee, Andrew H. S., Rakha, Emad A.
Publicado 2021